Stem Cell Banking Market: Opportunities & Challenges

CITY, Country, 2019-Oct-31 — /EPR Network/ —

The global stem cell banking market is projected to reach USD 9,415.4 million by 2023 from USD 6,290.6 million in 2018, at a CAGR of 8.4% from 2018 to 2023. Factors such as the growing awareness on the therapeutic potential of stem cells; development of novel technologies for stem cell preservation, processing and storage; increase in hematopoietic stem cell transplantation (HSCT) procedures; and increasing investments in stem cell-based research are driving the growth of the stem cell banking market. However, the high operational costs associated with stem cell banking and stringent regulatory frameworks are expected to restrain market growth to a certain extent.

What are the opportunities in emerging countries?

Developing countries are expected to offer significant growth opportunities for major players operating in the stem cell banking services market. This is mainly due to the growing per capita healthcare expenditure & disposable income, rising awareness regarding the clinical potential of stem cells, and supportive government regulations related to stem cell banking. In addition, the ongoing expansion and modernization of healthcare infrastructure, growing healthcare expenditure, and government initiatives to ensure the affordability and availability of healthcare services have made these countries attractive markets for companies specializing in stem cell banking.

Download PDF Brochure:

Governments across emerging countries are also increasingly supporting their domestic stem cell industry with favorable regulatory reforms in stem cell research, manufacturing, and banking services. Therefore, emerging countries are expected to offer significant growth opportunities to market stakeholders in the stem cell banking industry.

What challenges do socio-ethical concerns related to embryonic stem cells pose?

Stem cell products/therapies use human or animal-derived living cells. However, the use of allogeneic stem cells for human clinical applications is associated with several biosafety concerns, as these cells are derived from an unrelated source. Additionally, human embryonic stem cells are generated from destroying preimplantation-stage human embryos. Many religions strictly prohibit the destruction of human embryos for research purposes; hence, it is considered to be unethical.

Such concerns related to the use of allogeneic and embryonic stem cells have a major impact on their harvesting and preservation in stem cell banks. This factor is one of the major challenges for players in the global stem cell banking market

Request Sample Pages:

Browse Related Reports:

Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, Cvd, Surgery, and Agvhd), Cell Source (Adipose Tissue, Bone Marrow, Neural, Embryo/Cord Blood Derived, Ipscs) – Global Forecasts To 2021

Stem Cell Assay Market by Type (Viability, Purification, Identification), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instruments, Kits), Application (Regenerative Medicine, Clinical Research), End User – Global Forecast to 2023

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Shelly Singh
MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441


Visit Our Website:



Matched content

Editor’s pick

Express Press Release Distribution